Clinical trials in Norway is important for Norwegian companies
A new Norwegian technology enables cancer researchers to more easily share data
The school collaboration days were a little bit different this year …
The corona pandemic and international trade were on the top of the agenda when Nordic ministers met at OCC.
Our member Lytix Biopharma has entered into a milestone agreement
Molecular diagnostics, clinical studies and exercise plans for cancer patients were three key topics raised in last week’s event.